Review: Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuroregenerative Treatment of Multiple Sclerosis

Therapeutic Advances in Neurological Disorders - United Kingdom
doi 10.1177/1756285608098422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Awaiting Evidence of Neuroprotective Effects of Recombinant Erythropoietin in Very Preterm Infants

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2013English

Recombinant Human Erythropoietin vs Transfusions in the Treatment of Anemia of Prematurity

Archives of Pediatrics & Adolescent Medicine
1994English

Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial

Pediatrics
Child HealthPediatricsPerinatology
2010English

Effects of Recombinant Human Erythropoietin (R-HuEPO) Treatment on Cardiovascular Hemodynamics in Hemodialysis Patients

Journal of Japanese Society for Dialysis Therapy
1989English

Treatment of Multiple Sclerosis

Clinical Medicine and the Nervous System
1992English

Prospects for the Treatment of Multiple Sclerosis

Journal of the Royal Society of Medicine
Medicine
1991English

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Multiple Sclerosis - A Review

European Journal of Neurology
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy